Related Experiment Video
Updated: Jul 23, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Preparing for long-acting PrEP delivery: building on lessons from oral PrEP.
Connie Celum1, Beatriz Grinsztejn2, Kenneth Ngure3
1Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA.
Long-acting (LA) HIV pre-exposure prophylaxis (PrEP) offers new options to increase coverage and effectiveness. Lessons from oral PrEP delivery, focusing on service delivery and client support, are crucial for optimizing LA PrEP implementation.
Area of Science:
- Public Health
- Infectious Disease Prevention
- HIV/AIDS Research
Background:
- Recent approvals of long-acting (LA) HIV pre-exposure prophylaxis (PrEP), including injectable cabotegravir and the dapivirine ring, necessitate optimized delivery strategies.
- Leveraging lessons from a decade of oral PrEP delivery is essential for the successful implementation of new LA PrEP methods.
Purpose of the Study:
- To outline key considerations for optimizing the delivery of long-acting HIV pre-exposure prophylaxis (PrEP).
- To adapt successful strategies from oral PrEP delivery for new long-acting formulations.
- To enhance HIV prevention coverage, adherence, persistence, and effectiveness through expanded PrEP options.
Main Methods:
- Framing LA PrEP delivery around differentiated service delivery building blocks.
- Identifying critical factors: population reach, service location, user burden reduction, and service integration.
- Incorporating community co-development for demand creation and education, provider training, and tailored adherence support.
Main Results:
- Optimizing LA PrEP delivery requires strategic planning for accessibility, user convenience, and integration with other health services.
- Effective demand creation, informed client decision-making, and comprehensive provider training are vital for successful uptake.
- Tailored adherence support and flexible service delivery models (e.g., telePrEP, pharmacy-based) are crucial for persistence.
Conclusions:
- Expanding PrEP options with LA formulations can increase coverage, adherence, persistence, and effectiveness by meeting diverse individual needs.
- Lessons learned from oral PrEP delivery regarding demand creation, client engagement, provider education, adherence support, and service models are directly applicable to LA PrEP implementation.
- Integrated service delivery models are essential for maximizing the impact of LA PrEP within broader HIV prevention and sexual health programs.
Related Concept Videos
Drug Delivery: Enteral Route
Factors Influencing Drug Absorption: Presystemic Elimination
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

